查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1865430

全球真菌生物防治市場：預測至2032年－依產品類型、配方、作用機制、應用及地區分類的分析

Fungal Disease Biocontrol Market Forecasts to 2032 - Global Analysis By Product Type, Formulation, Mode of Action (Competition, Parasitism & Predation, Antibiosis, and Induced Systemic Resistance ), Application, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計到 2025 年，全球真菌生物防治市場價值將達到 13 億美元，到 2032 年將達到 40 億美元。

預計在預測期內，生物防治市場將以16.6%的複合年成長率成長。真菌病害的生物防治是指策略性地利用生物體（主要是有益真菌、細菌或天然拮抗劑）來抑製或消除影響植物、動物和生態系統的致病真菌。這種環境永續的方法透過競爭排斥、寄生或誘導抗性來降低病害發生率，而無需依賴化學殺菌劑。生物防治劑的選擇是基於其特異性、有效性和對生態系統影響的最小性，使其成為綜合蟲害管理（IPM）和農業長期韌性的重要組成部分。

根據聯合國糧食及農業組織（糧農組織）的數據，每年全球高達 40% 的農作物產量因病蟲害而損失，造成超過 2,200 億美元的損失。

有機和永續農業的發展趨勢

隨著監管機構和消費者越來越支持環境友善作物保護方法，生物防治劑的需求正在蓬勃發展。這些解決方案能夠減少化學殘留，改善土壤健康，並符合有機認證標準。此外，政府補貼和支持永續投入的宣傳宣傳活動也進一步推動了生物防治劑的普及。預計這一趨勢將在預測期內持續增強市場成長動能。

與化學農藥相比，起效較慢

這種延遲起效在高壓病害環境下可能是個顯著的缺點，因為在這些環境下，快速介入至關重要。此外，由於環境差異導致的田間藥效差異也會阻礙大規模種植者採用此產品。雖然目前正在進行研究以提高製劑穩定性和起效速度，但延遲起效已被認為是影響市場滲透的主要阻礙因素，尤其是在集約化農業系統發達的地區。

多功能產品的開發

多功能製劑結合了拮抗、競爭和誘導抗性等多種作用機制，可提供更全面的保護並提高可靠性。此外，多功能製劑還能降低病原體產生抗藥性的風險，並更適用於綜合蟲害管理（IPM）方案。隨著研究機構和生物技術公司對新型菌株和協同製劑技術的投資，市場有望受益於能夠滿足多樣化作物保護需求的差異化產品。

來自新型化學殺菌劑的競爭

真菌病害生物防治市場面臨新一代化學殺菌劑的競爭壓力，這些化學殺菌劑具有起效迅速、廣譜高效和保存期限長等優點。這些合成替代品通常採用先進的施用系統且施用成本低廉，因此對傳統種植者極具吸引力。此外，農業化學品生產商積極的行銷和分銷網路可能會掩蓋生物防治方案的影響力。除非生物製劑展現出與之相當的性能和擴充性，否則化學創新帶來的威脅可能會阻礙市場成長，尤其是在監管較為寬鬆的地區。

新冠疫情的影響：

新冠疫情擾亂了供應鏈，延誤了田間試驗，並暫時減緩了真菌生物防治劑的應用。然而，這場危機也帶來了契機，促使人們更加關注永續糧食生產，並減少對化學物質的依賴。封鎖和勞動力短缺迫使農民尋求更具韌性、投入更少的解決方案，間接推動了生物防治劑的應用。此外，疫情後農業生物技術投入的增加以及對糧食安全的重新關注，為市場的長期復甦創造了有利條件。

預計在預測期內，微生物學領域將佔據最大的市場佔有率。

由於微生物製劑已被證實具有顯著功效，且適用於多種作物，預計在預測期內，微生物製劑將佔據最大的市場佔有率。木黴屬、芽孢桿菌屬和假單胞菌屬等微生物製劑因其拮抗特性和與有機農業的兼容性而被廣泛應用。它們能夠定殖於植物根系並透過多種機制抑制病原體，因此深受種植者的青睞。此外，製劑技術的進步和監管核准的獲批進一步增強了商業性可行性，鞏固了其市場主導地位。

預計在預測期內，誘導系統性阻力（ISR）板塊的複合年成長率將最高。

預計在預測期內，誘導系統抗性（ISR）領域將實現最高成長率，這主要得益於其增強植物對多種真菌病原體免疫力的能力。基於ISR的生物防治劑能夠活化植物的內部防禦機制，提供持久的保護，而無需直接針對病原體。這種作用機轉在綜合蟲害管理系統中尤其重要。此外，ISR產品在高價值園藝作物中也越來越受歡迎，因為在這些作物中，零殘留解決方案至關重要，這也有助於其加速推廣應用並提高複合年成長率。

佔比最大的地區：

預計在預測期內，歐洲地區將佔據最大的市場佔有率，這主要得益於鼓勵生物防治劑使用的嚴格法規結構以及有機農業的廣泛應用。法國、德國和荷蘭等國積極透過補貼和研究舉措推廣生物防治技術。此外，消費者對無殘留產品的需求不斷成長，以及對環境管理的日益重視，也推動了市場成長。主要生物防治劑生產商的存在以及合作研發項目進一步鞏固了歐洲在真菌病害生物防治市場的主導地位。

預計複合年成長率最高的地區：

預計亞太地區在預測期內將實現最高的複合年成長率，這主要得益於人們對永續農業的日益關注以及減少化學農藥使用的壓力不斷增大。印度、中國和越南等新興經濟體由於政府主導的措施和有機農地的擴張，正迅速採用生物防治劑。此外，該地區多樣化的氣候條件和作物特性也催生了對客製化真菌生物防治解決方案的強勁需求。策略夥伴關係和在地化生產也促進了市場的加速成長。

免費客製化服務

訂閱本報告的用戶可從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 引言

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 分析方法
  • 分析材料
    • 原始研究資料
    • 二手研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球真菌病害生物防治市場（依產品類型分類）

  • 介紹
  • 微生物
    • 細菌
    • 真菌
    • 酵母菌
  • 植物成分和植物萃取物
  • 礦物

6. 全球真菌生物防治市場（依製劑分類）

  • 介紹
  • 濕劑型（液體）
    • 水溶液
    • 乳液
  • 乾粉劑型
    • 可濕性粉
    • 顆粒

7. 全球真菌病害生物防治市場（依作用機制分類）

  • 介紹
  • 競賽
  • 寄生/捕食
  • 抗生素
  • 誘導系統性抵抗（ISR）

8. 全球真菌病害生物防治市場（依應用領域分類）

  • 介紹
  • 農業
    • 水果和蔬菜
    • 糧食
    • 油籽/豆類
    • 其他作物
  • 園藝和室內植物
  • 草坪和造景管理
  • 收穫後用途

9. 全球真菌病害生物防治市場（依地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併（M&A）
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章 企業概況

  • BASF SE
  • Bayer AG
  • Syngenta AG
  • Corteva Agriscience, Inc.
  • FMC Corporation
  • UPL Limited
  • Valent Biosciences Corporation
  • Certis USA LLC
  • Koppert BV
  • Marrone Bio Innovations, Inc.
  • BIOWORKS, Inc.
  • Andermatt Biocontrol AG
  • Novozymes A/S
  • Isagro SpA
  • Nufarm Limited
Product Code: SMRC32193

According to Stratistics MRC, the Global Fungal Disease Biocontrol Market is accounted for $1.3 billion in 2025 and is expected to reach $4.0 billion by 2032, growing at a CAGR of 16.6% during the forecast period. Fungal disease biocontrol is the strategic use of living organism's primarily beneficial fungi, bacteria, or natural antagonists to suppress or eliminate pathogenic fungi affecting plants, animals, or ecosystems. This environmentally sustainable approach leverages competitive exclusion, parasitism, or induced resistance to reduce disease incidence without relying on chemical fungicides. Biocontrol agents are selected for their specificity, efficacy, and minimal ecological disruption, making them integral to integrated pest management and long-term agricultural resilience.

According to FAO, up to 40% of global crop production is lost to pests and diseases each year, costing over $220 billion.

Market Dynamics:

Driver:

Growing organic farming and sustainable agriculture trends

As regulatory bodies and consumers increasingly favor eco-friendly crop protection methods, demand for biological control agents has surged. These solutions offer reduced chemical residues and improved soil health, aligning with organic certification standards. Moreover, government subsidies and awareness campaigns supporting sustainable inputs have further accelerated adoption. This trend is expected to continue strengthening the market's growth trajectory throughout the forecast period.

Restraint:

Slower action compared to chemical alternatives

This delayed efficacy can be a critical drawback in high-pressure disease environments where rapid intervention is essential. Additionally, inconsistent field performance due to environmental variability may deter adoption among large-scale growers. While ongoing research aims to enhance formulation stability and speed of action, the perceived lag in results remains a significant restraint impacting market penetration, particularly in regions with intensive farming systems.

Opportunity:

Development of multi-mode action products

Multi-mode action formulations combine mechanisms such as antagonism, competition, and induced resistance, offering broader-spectrum protection and improved reliability. Furthermore, multi-functional agents reduce the risk of pathogen resistance and enhance compatibility with integrated pest management (IPM) programs. As research institutions and biotech firms invest in novel strains and synergistic blends, the market is poised to benefit from differentiated offerings that meet diverse crop protection needs.

Threat:

Competition from new chemical fungicides

The fungal disease biocontrol market faces competitive pressure from next-generation chemical fungicides that offer rapid action, broad-spectrum efficacy, and longer shelf life. These synthetic alternatives often come with advanced delivery systems and lower application costs, making them attractive to conventional growers. Moreover, aggressive marketing and distribution networks of agrochemical companies can overshadow biocontrol solutions. Unless biological agents demonstrate comparable performance and scalability, the threat from chemical innovations may hinder market growth, especially in regions with limited regulatory restrictions.

Covid-19 Impact:

The COVID-19 pandemic disrupted supply chains and delayed field trials, temporarily slowing the adoption of fungal biocontrol agents. However, the crisis also heightened awareness around sustainable food production and reduced chemical dependency. Lockdowns and labor shortages prompted growers to seek resilient, low-input solutions, indirectly supporting biocontrol uptake. Additionally, increased funding for agricultural biotechnology and renewed focus on food security post-pandemic have created favorable conditions for long-term market recovery.

The microbials segment is expected to be the largest during the forecast period

The microbials segment is expected to account for the largest market share during the forecast period due to its proven efficacy and wide applicability across crops. Microbial agents such as Trichoderma, Bacillus, and Pseudomonas species are extensively used for their antagonistic properties and compatibility with organic farming. Their ability to colonize plant roots and suppress pathogens through multiple mechanisms makes them a preferred choice among growers. Moreover, advancements in formulation technologies and regulatory approvals have further strengthened their commercial viability, solidifying their dominance in the market.

The induced systemic resistance (ISR) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the induced systemic resistance (ISR) segment is predicted to witness the highest growth rate driven by its ability to enhance plant immunity against a broad range of fungal pathogens. ISR-based biocontrol agents activate the plant's internal defense pathways, offering long-lasting protection without direct pathogen targeting. This mode of action is particularly valuable in integrated pest management systems. Furthermore, ISR products are gaining traction in high-value horticultural crops, where residue-free solutions are critical, contributing to their accelerated adoption and CAGR.

Region with largest share:

During the forecast period, the Europe region is expected to hold the largest market share propelled by stringent regulatory frameworks favoring biological inputs and widespread organic farming practices. Countries such as France, Germany, and the Netherlands have actively promoted biocontrol adoption through subsidies and research initiatives. Additionally, consumer demand for residue-free produce and environmental stewardship has driven market growth. The presence of key biocontrol manufacturers and collaborative R&D programs further reinforces Europe's leadership position in the fungal disease biocontrol landscape.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by rising awareness of sustainable agriculture and increasing pressure to reduce chemical pesticide use. Emerging economies such as India, China, and Vietnam are witnessing rapid adoption of biocontrol agents due to government-led initiatives and expanding organic acreage. Moreover, the region's diverse climatic conditions and crop profiles create a robust demand for tailored fungal biocontrol solutions. Strategic partnerships and local manufacturing are also contributing to accelerated market growth.

Key players in the market

Some of the key players in Fungal Disease Biocontrol Market include BASF SE, Bayer AG, Syngenta AG, Corteva Agriscience, Inc., FMC Corporation, UPL Limited, Valent Biosciences Corporation, Certis USA L.L.C., Koppert B.V., Marrone Bio Innovations, Inc., BIOWORKS, Inc., Andermatt Biocontrol AG, Novozymes A/S, Isagro S.p.A., and Nufarm Limited.

Key Developments:

In September 2025, Syngenta partnered with Lavie Bio to develop novel biological insecticidal solutions, targeting sustainable insect and disease management, leveraging innovative bio-technology platforms.

In September 2025, Corteva introduced Zorvec Entecta, a fungicide protecting grapes and potatoes from Downy Mildew and Late Blight, featuring stable rain fastness and systemic mobility. The product supports growers with sustainable disease control.

In January 2025, UPL acquired Corteva's mancozeb business including the Dithane(R) fungicide, a trusted broad-spectrum fungicide effective against multiple fungal diseases with an improved Rainshield(TM) formulation for better disease control and environmental compliance.

Product Types Covered:

  • Microbials
  • Botanicals & Plant Extracts
  • Minerals

Formulations Covered:

  • Wet Formulations (Liquid)
  • Dry Formulations

Mode of Actions Covered:

  • Competition
  • Parasitism & Predation
  • Antibiosis
  • Induced Systemic Resistance (ISR)

Applications Covered:

  • Agriculture
  • Horticulture & Ornamentals
  • Turf & Landscape Management
  • Post-Harvest Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Fungal Disease Biocontrol Market, By Product Type

  • 5.1 Introduction
  • 5.2 Microbials
    • 5.2.1 Bacteria
    • 5.2.2 Fungi
    • 5.2.3 Yeasts
  • 5.3 Botanicals & Plant Extracts
  • 5.4 Minerals

6 Global Fungal Disease Biocontrol Market, By Formulation

  • 6.1 Introduction
  • 6.2 Wet Formulations (Liquid)
    • 6.2.1 Aqueous Solutions
    • 6.2.2 Emulsifiable Concentrates
  • 6.3 Dry Formulations
    • 6.3.1 Wettable Powders
    • 6.3.2 Granules

7 Global Fungal Disease Biocontrol Market, By Mode of Action

  • 7.1 Introduction
  • 7.2 Competition
  • 7.3 Parasitism & Predation
  • 7.4 Antibiosis
  • 7.5 Induced Systemic Resistance (ISR)

8 Global Fungal Disease Biocontrol Market, By Application

  • 8.1 Introduction
  • 8.2 Agriculture
    • 8.2.1 Fruits & Vegetables
    • 8.2.2 Cereals & Grains
    • 8.2.3 Oilseeds & Pulses
    • 8.2.4 Other Crops
  • 8.3 Horticulture & Ornamentals
  • 8.4 Turf & Landscape Management
  • 8.5 Post-Harvest Applications

9 Global Fungal Disease Biocontrol Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 BASF SE
  • 11.2 Bayer AG
  • 11.3 Syngenta AG
  • 11.4 Corteva Agriscience, Inc.
  • 11.5 FMC Corporation
  • 11.6 UPL Limited
  • 11.7 Valent Biosciences Corporation
  • 11.8 Certis USA L.L.C.
  • 11.9 Koppert B.V.
  • 11.10 Marrone Bio Innovations, Inc.
  • 11.11 BIOWORKS, Inc.
  • 11.12 Andermatt Biocontrol AG
  • 11.13 Novozymes A/S
  • 11.14 Isagro S.p.A.
  • 11.15 Nufarm Limited

List of Tables

  • Table 1 Global Fungal Disease Biocontrol Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Fungal Disease Biocontrol Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Fungal Disease Biocontrol Market Outlook, By Microbials (2024-2032) ($MN)
  • Table 4 Global Fungal Disease Biocontrol Market Outlook, By Bacteria (2024-2032) ($MN)
  • Table 5 Global Fungal Disease Biocontrol Market Outlook, By Fungi (2024-2032) ($MN)
  • Table 6 Global Fungal Disease Biocontrol Market Outlook, By Yeasts (2024-2032) ($MN)
  • Table 7 Global Fungal Disease Biocontrol Market Outlook, By Botanicals & Plant Extracts (2024-2032) ($MN)
  • Table 8 Global Fungal Disease Biocontrol Market Outlook, By Minerals (2024-2032) ($MN)
  • Table 9 Global Fungal Disease Biocontrol Market Outlook, By Formulation (2024-2032) ($MN)
  • Table 10 Global Fungal Disease Biocontrol Market Outlook, By Wet Formulations (Liquid) (2024-2032) ($MN)
  • Table 11 Global Fungal Disease Biocontrol Market Outlook, By Aqueous Solutions (2024-2032) ($MN)
  • Table 12 Global Fungal Disease Biocontrol Market Outlook, By Emulsifiable Concentrates (2024-2032) ($MN)
  • Table 13 Global Fungal Disease Biocontrol Market Outlook, By Dry Formulations (2024-2032) ($MN)
  • Table 14 Global Fungal Disease Biocontrol Market Outlook, By Wettable Powders (2024-2032) ($MN)
  • Table 15 Global Fungal Disease Biocontrol Market Outlook, By Granules (2024-2032) ($MN)
  • Table 16 Global Fungal Disease Biocontrol Market Outlook, By Mode of Action (2024-2032) ($MN)
  • Table 17 Global Fungal Disease Biocontrol Market Outlook, By Competition (2024-2032) ($MN)
  • Table 18 Global Fungal Disease Biocontrol Market Outlook, By Parasitism & Predation (2024-2032) ($MN)
  • Table 19 Global Fungal Disease Biocontrol Market Outlook, By Antibiosis (2024-2032) ($MN)
  • Table 20 Global Fungal Disease Biocontrol Market Outlook, By Induced Systemic Resistance (ISR) (2024-2032) ($MN)
  • Table 21 Global Fungal Disease Biocontrol Market Outlook, By Application (2024-2032) ($MN)
  • Table 22 Global Fungal Disease Biocontrol Market Outlook, By Agriculture (2024-2032) ($MN)
  • Table 23 Global Fungal Disease Biocontrol Market Outlook, By Fruits & Vegetables (2024-2032) ($MN)
  • Table 24 Global Fungal Disease Biocontrol Market Outlook, By Cereals & Grains (2024-2032) ($MN)
  • Table 25 Global Fungal Disease Biocontrol Market Outlook, By Oilseeds & Pulses (2024-2032) ($MN)
  • Table 26 Global Fungal Disease Biocontrol Market Outlook, By Other Crops (2024-2032) ($MN)
  • Table 27 Global Fungal Disease Biocontrol Market Outlook, By Horticulture & Ornamentals (2024-2032) ($MN)
  • Table 28 Global Fungal Disease Biocontrol Market Outlook, By Turf & Landscape Management (2024-2032) ($MN)
  • Table 29 Global Fungal Disease Biocontrol Market Outlook, By Post-Harvest Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.